The DOI matches its Crossref record; 39 of the 42 references it cites were found in a registry or an index.
Cannabis use predicts future psychotic symptoms, and vice versa
Abstract
AIMS: To assess if cannabis use is a risk factor for future psychotic symptoms, and vice versa, in adolescents and young adults from the general population. DESIGN: Cohort study. SETTING/PARTICIPANTS: 'Zuid Holland' study, a 14-year follow-up study of 1580 initially 4-16-year-olds who were drawn randomly from the Dutch general population. Because cannabis use is generally condoned in the Netherlands, false-negative reports of cannabis use may occur less frequently than in countries with stricter drug policies, which supports the value of the present study. MEASUREMENTS: Life-time cannabis use and psychotic symptoms, assessed with the Composite International Diagnostic Interview (CIDI). FINDINGS: Cannabis use, in individuals who did not have psychotic symptoms before they began using cannabis, predicted future psychotic symptoms (hazard ratio = 2.81; 95% confidence interval = 1.79-4.43). However, psychotic symptoms in those who had never used cannabis before the onset of psychotic symptoms also predicted future cannabis use (hazard ratio = 1.70; 95% confidence interval = 1.13-2.57). CONCLUSIONS: The results imply either a common vulnerability with varying order of onset or a bi-directional causal relationship between cannabis use and psychosis. More research on patterns and timings of these relationships is needed to narrow down the possibilities.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“Evidence from most case-control and cross-sectional studies support an association between cannabis use and schizophrenia (4-6) and psychotic symptoms (7)(8)(9).”
From Association Between Cannabis and Psychosis: Epidemiologic Evidence (2016) · cites this paper as [7]
Citations
Cites
Regression Models and Life-Tables
Cox, D. R. (1972) · Journal of the Royal Statistical Society Series B: Statistical Methodology · doi:10.1111/j.2517-6161.1972.tb00899.x · Cited by 39,793
Regression Models and Life-Tables
Cox, D. R. (1992) · Springer Series in Statistics · doi:10.1007/978-1-4612-4380-9_37 · Cited by 26,297
(1998) · The Journal of Clinical Psychiatry · Cited by 19,139
Regier, D. A. (1990) · JAMA · doi:10.1001/jama.1990.03450190043026 · Cited by 3,962
Robins, L. N. (1988) · Archives of General Psychiatry · doi:10.1001/archpsyc.1988.01800360017003 · Cited by 2,909
Kessler, R. C. (1997) · Archives of General Psychiatry · doi:10.1001/archpsyc.1997.01830160031005 · Cited by 2,085
Cannabis use in adolescence and risk for adult psychosis: longitudinal prospective study.
Arseneault, L., Cannon, M., Poulton, R., Murray, R., Caspi, A., & Moffitt, T. E. (2002) · BMJ · doi:10.1136/bmj.325.7374.1212 · Cited by 1,399
Cannabis and schizophrenia. A longitudinal study of Swedish conscripts
Andréasson, S., Engström, A., Allebeck, P., & Rydberg, U. (1987) · The Lancet · doi:10.1016/s0140-6736(87)92620-1 · Cited by 1,166
THE CONTINUITY OF PSYCHOTIC EXPERIENCES IN THE GENERAL POPULATION
Johns, L. C., & van Os, J. (2001) · Clinical Psychology Review · doi:10.1016/s0272-7358(01)00103-9 · Cited by 960
Cannabis use and psychosis: A longitudinal population-based study
van Os, J. (2002) · American Journal of Epidemiology · doi:10.1093/aje/kwf043 · Cited by 928
Cited by
Sorted by citations
Items 101–200 of 214
Cognitive mechanisms in cannabis-related paranoia; Initial testing and model proposal
Newman‐Taylor, K., Richardson, T. H., Sood, M., Sopp, M., Perry, E., & Bolderston, H. (2020) · Psychosis · doi:10.1080/17522439.2020.1757742 · Cited by 17
The Changing Legal Landscape of Cannabis Use and Its Role in Youth-onset Psychosis
Wright, A., Cather, C., Gilman, J., & Evins, A. E. (2020) · Child and Adolescent Psychiatric Clinics of North America · doi:10.1016/j.chc.2019.08.016 · Cited by 16
Effects of Cannabis Use on Psychotic and Mood Symptoms: A Systematic Review
Polkosnik, G. L., Sorkhou, M., & George, T. P. (2021) · The Canadian Journal of Addiction · doi:10.1097/cxa.0000000000000124 · Cited by 16
CANNABIS‐RELATED PSYCHOSIS AND THE GENE–ENVIRONMENT INTERACTION: COMMENTS ON FERDINAND ET AL. 2005
van Os, J., Henquet, C., & Stefanis, N. C. (2005) · Addiction · doi:10.1111/j.1360-0443.2005.01083.x · Cited by 15
Giudice, M. D. (2010) · PLoS ONE · doi:10.1371/journal.pone.0016040 · Cited by 14
Nagar, M., & Rabinovitz, S. (2015) · Journal of Psychoactive Drugs · doi:10.1080/02791072.2015.1029654 · Cited by 14
Raynal, P., & Chabrol, H. (2016) · Addictive Behaviors · doi:10.1016/j.addbeh.2016.04.018 · Cited by 14
Early cannabis use and its relation to the development of psychiatric disorders: a review
Roncero, C., Servicio de Psiquiatría, C. A. U. D. S. (., Palma-Álvarez, R. F., Barrau, V., Urbano, N., Martínez‐Luna, N., Ortiz-Medina, M. B., Daigre, C., & Departamento de Psiquiatría, U. A. D. B. (2017) · Salud Mental · doi:10.17711/sm.0185-3325.2017.037 · Cited by 14
Johnstad, P. G. (2022) · Drug Science Policy and Law · doi:10.1177/20503245221095228 · Cited by 12
Cannabis, Cannabinoids, and the Association with Psychosis
Radhakrishnan, R., Addy, P. H., Sewell, R. A., Skosnik, P. D., Ranganathan, M., & D’Souza, D. C. (2014) · Elsevier eBooks · doi:10.1016/b978-0-12-418679-8.00014-9 · Cited by 12
Novel directions for G × E analysis in psychiatry
Vinkhuyzen, A. A. E., & Wray, N. R. (2014) · Epidemiology and Psychiatric Sciences · doi:10.1017/s2045796014000584 · Cited by 12
Is there sufficient evidence that cannabis use is a risk factor for psychosis?
Colizzi, M., & Bhattacharyya, S. (2020) · Elsevier eBooks · doi:10.1016/b978-0-12-813201-2.00016-8 · Cited by 11
A developmental approach to violence, hostile attributions, and paranoid thinking in adolescence
Bailey, S. M., Whittle, N., Farnworth, P., & Smedley, K. (2007) · Behavioral Sciences & the Law · doi:10.1002/bsl.776 · Cited by 10
Clinical Manual of Prevention in Mental Health
(2009) · American Psychiatric Association Publishing eBooks · doi:10.1176/appi.books.9781615378029 · Cited by 10
The Association Between Cannabinoids and Psychosis
Tikka, S. K., & D’Souza, D. C. (2018) · Springer eBooks · doi:10.1007/978-3-319-90365-1_14 · Cited by 10
Berger, A., Khan, M. R., & Hemberg, J. (2012) · Journal of Addictive Diseases · doi:10.1080/10550887.2012.665691 · Cited by 10
Doppeldiagnose Psychose und Sucht - Grundlagen und Therapie
Gouzoulis‐Mayfrank, E. (2008) · Zeitschrift für Kinder- und Jugendpsychiatrie und Psychotherapie · doi:10.1024/1422-4917.36.4.245 · Cited by 10
Environmental Risk Factors for Schizophrenia
McGrath, J. J., & Murray, R. M. (2010) · Wiley eBooks · doi:10.1002/9781444327298.ch11 · Cited by 10
Veling, W. (2008) · RePub (Erasmus University Rotterdam) · Cited by 10
Forti, M. D., Bond, B. W., Spinazzola, E., Trotta, G., Lynn, J., Malkin, R., Siddiqui, N. K., Demir, S., Opadokun, T., Leung, P. B. M., et al. (2024) · BJPsych Open · doi:10.1192/bjo.2024.782 · Cited by 9
Prevalence of cannabis use in people with psychosis in KwaZulu-Natal, South Africa
Mona, K., Ntlantsana, V., Tomita, A. M., & Paruk, S. (2022) · South African Journal of Psychiatry · doi:10.4102/sajpsychiatry.v28i0.1927 · Cited by 9
Impact of Substance Use Disorder on Presentation of Schizophrenia
Chaudhury, S., Tikka, S. K., & Bakhla, A. K. (2016) · Dual Diagnosis Open Access · doi:10.21767/2472-5048.100007 · Cited by 9
L’impact du cannabis à l’adolescence sur la transition psychotique de l’adulte
Krebs, M., Gut, A., Plaze, M., & Dervaux, A. (2013) · Neuropsychiatrie de l Enfance et de l Adolescence · doi:10.1016/j.neurenf.2013.03.001 · Cited by 8
Relationships between substance use and hypomanic symptoms in a non-clinical sample.
Richardson, T. H., & Garavan, H. (2011) · Mental Health and Substance Use · doi:10.1080/17523281.2010.509845 · Cited by 8
Matsumoto, T., Kawabata, T., Okita, K., Tanibuchi, Y., Funada, D., Murakami, M., Usami, T., Yokoyama, R., Naruse, N., Aikawa, Y., et al. (2020) · Neuropsychopharmacology Reports · doi:10.1002/npr2.12133 · Cited by 8
Lange, J. E., Moyers, S. A., & Croff, J. M. (2023) · Public Administration Quarterly · doi:10.37808/paq.47.3.7 · Cited by 6
Procter, N. G., Hamer, H. P., McGarry, D. E., Wilson, R. L., & Froggatt, T. (2018) · Cambridge University Press eBooks · doi:10.1017/9781316718278 · Cited by 6
Spinazzola, E., Quattrone, D., Rodríguez, V., Trotta, G., Alameda, L., Tripoli, G., Gayer-Anderson, C. E., Freeman, T. P., Johnson, E. C., Jongsma, H. E., et al. (2023) · Psychological Medicine · doi:10.1017/s0033291723001071 · Cited by 6
Self-citationIshii, J., Kodaka, F., Miyata, H., Yamadera, W., Seto, H., Inamura, K., Higuchi, H., Tsuruoka, Y., & Shigeta, M. (2020) · PLoS ONE · doi:10.1371/journal.pone.0240504 · Cited by 6
Segura, À. G., Mané, A., Prohens, L., Rodríguez, N., Mezquida, G., Cuesta, M. J., Vieta, E., Amoretti, S., Lobo, A., González-Pinto, A. M., et al. (2023) · Psychiatry Research · doi:10.1016/j.psychres.2023.115249 · Cited by 5
Is cannabis responsible for early onset psychotic illnesses?
Dervaux, A., Krebs, M., & Laqueille, X. (2011) · Neuropsychiatry · doi:10.2217/npy.11.31 · Cited by 5
Which cannabis users develop psychosis?
Forti, M. D., Henquet, C., Verdoux, H., Murray, R. M., & van Os, J. (2011) · Cambridge University Press eBooks · doi:10.1017/cbo9780511706080.013 · Cited by 5
Clearing The Smoke On Cannabis
Meducator, T., Cui, E., & Rayner, D. G. (2019) · The Meducator · doi:10.15173/m.v1i35.2207 · Cited by 5
Δ9-tetrahydrocannabinol: harmful even in low doses?
Hjorthøj, C. R., & Posselt, C. M. (2020) · The Lancet Psychiatry · doi:10.1016/s2215-0366(20)30093-6 · Cited by 5
Wang, N., Yao, T., Sung, H., & Max, W. B. (2021) · Substance Use & Misuse · doi:10.1080/10826084.2021.1995758 · Cited by 4
Iyegbe, C. O., Modinos, G., & Rivera, M. (2012) · InTech eBooks · doi:10.5772/36075 · Cited by 3
Cannabinoids: Drug or Medication?
Giron, L., & Befort, K. (2016) · InTech eBooks · doi:10.5772/63172 · Cited by 4
Neuroethics and cannabis use globally: Impact on adolescent cognition and wellbeing
Selamoglu, A., Malinowska, A., Savulich, G., & Sahakian, B. J. (2020) · Elsevier eBooks · doi:10.1016/b978-0-12-815063-4.00012-5 · Cited by 3
The Interface of Cannabis Misuse and Schizophrenia-Spectrum Disorders
Ramsay, C. E., & Compton, M. T. (2011) · Springer eBooks · doi:10.1007/978-94-007-0834-1_14 · Cited by 4
Cannabis and Psychosis: A Review of the Risk Factors Involved
Amar, M. B. (2020) · American Journal of Plant Sciences · doi:10.4236/ajps.2020.1112139 · Cited by 3
Castañeda, C. P., Alliende, L. M., Iruretagoyena, B., Nachar, R., Mancilla, F., Díaz, C., Gallardo, C., Mena, C., Ramírez-Mahaluf, J. P., Undurraga, J. P., et al. (2020) · Revista médica de Chile · doi:10.4067/s0034-98872020001101606 · Cited by 3
Bernusky, H. C. R., Tibbo, P. G., Conrod, P., Yunus, F. M., Keough, M. T., Thompson, K., Krank, M. D., Hadwin, A. F., & Stewart, S. H. (2023) · Addictive Behaviors · doi:10.1016/j.addbeh.2023.107937 · Cited by 3
Does cannabis use cause schizophrenia? The epidemiological evidence
Zammit, S., Arseneault, L., & Murray, R. M. (2011) · Cambridge University Press eBooks · doi:10.1017/cbo9780511706080.016 · Cited by 3
Le cannabis et ses effets délétères : pour un débat plus nuancé
Jobidon, L., & Jutras‐Aswad, D. (2018) · Drogues santé et société · doi:10.7202/1044306ar · Cited by 3
Genetic mediation of the link between schizophrenia and cannabis use
Veling, W. (2008) · Psychiatry · doi:10.1016/j.mppsy.2008.10.007 · Cited by 3
Psychotomimetic and Cognitive Effects of Cannabis Use in the General Population
Solowij, N. (2017) · Elsevier eBooks · doi:10.1016/b978-0-12-804791-0.00005-7 · Cited by 3
Cannon, M. D., Harley, M., Clarke, M. C., & Arseneault, L. (2006) · CRC Press eBooks · doi:10.1201/b14457-17 · Cited by 3
Baral, A., Dubois, C., Kumar, L., Devkota, J., Vidot, D. C., Vandrey, R. G., & Thrul, J. (2026) · Addiction · doi:10.1111/add.70474 · Cited by 2
Gennaro, G. D., & Colizzi, M. (2023) · Epidemiology and Psychiatric Sciences · doi:10.1017/s2045796023000537 · Cited by 2
Compton, M. T., Koplan, C. R., Oleskey, C., Powers, R. A., Pruitt, D. B., & Wissow, L. (2009) · American Psychiatric Association Publishing eBooks · doi:10.1176/appi.books.9781615378029.lg01 · Cited by 2
Prenatal Cannabis Exposure and Infant Development: “A Tolerated Matter”
Marroun, H. E. (2010) · Cited by 2
Traumatic experience, cannabis use, life satisfaction, and schizotypy
Fleming, S., Mallett, J., Murphy, J., & Shevlin, M. E. (2011) · Psychosis · doi:10.1080/17522439.2011.587527 · Cited by 2
Wan, C. R., & Broussard, B. (2017) · Elsevier eBooks · doi:10.1016/b978-0-12-804791-0.00011-2 · Cited by 2
Campbell-Williams, K. A., Oshi, D. C., Whitehorne-Smith, P., & Abel, W. D. (2018) · Journal of Substance Use · doi:10.1080/14659891.2018.1552729 · Cited by 2
Genetic Risk of Psychosis in Relation to Cannabis Use: Findings from Polygenic Risk Score Approaches
Adorjan, K., & Papiol, S. (2019) · Journal of Psychiatry and Brain Science · doi:10.20900/jpbs.20190018 · Cited by 3
Understanding cannabis use in schizophrenia
Kavanagh, D. J., & Mueser, K. T. (2011) · Cambridge University Press eBooks · doi:10.1017/cbo9780511706080.021 · Cited by 2
Substance-induced psychosis: an overview
Thirthalli, J., Benegal, V., & Gangadhar, B. N. (2010) · Cambridge University Press eBooks · doi:10.1017/cbo9780511789977.009 · Cited by 2
Ringen, P. A. (2009) · NORA - Norwegian Open Research Archives · Cited by 2
Penney, S. R., Jones, R. M., Wilkie, T., Gerritsen, C. J., Chatterjee, S., Chaimowitz, G. A., & Simpson, A. I. F. (2024) · International Journal of Drug Policy · doi:10.1016/j.drugpo.2024.104622 · Cited by 1
Es realmente el consumo de cannabis un factor de riesgo para la esquizofrenia
Erdozain, A. M., Muguruza, C., Meana, J. J., & Callado, L. F. (2009) · Dialnet (Universidad de la Rioja) · Cited by 1
Appraising the risks of reefer madness.
Murray, R. M. (2015) · PubMed Central · Cited by 1
Hjorthøj, C. R., Stürup, A. E., Karlsen, M., Speyer, H., Osler, M., Öngür, D., & Nordentoft, M. (2024) · Psychological Medicine · doi:10.1017/s0033291724000758 · Cited by 1
Blanchard, B. E. (2013) · NC Digital Online Collection of Knowledge and Scholarship (The University of North Carolina at Greensboro) · Cited by 1
Cannabidiol as a Potential Novel Therapeutic Agent for Psychotic Disorders
Deiana, S., & Zamberletti, E. (2017) · Elsevier eBooks · doi:10.1016/b978-0-12-804791-0.00014-8 · Cited by 1
Niemelä, S. (2008) · UTUPub (University of Turku) · Cited by 1
Co-morbidity and cannabis use in a mental health trust in South East England
Trathen, B., OʼGara, C., Sarkhel, A., Sessay, M., Rao, H., & Luty, J. S. (2007) · Addictive Behaviors · doi:10.1016/j.addbeh.2007.02.015 · Cited by 1
Konings, M., & Maharajh, H. D. (2007) · International Journal on Disability and Human Development · doi:10.1515/ijdhd.2007.6.1.29 · Cited by 1
Onset, course and comorbidity of bipolar symptoms in population and treatment settings
Rossum, I. W.-V. (2010) · Research Publications (Maastricht University) · doi:10.26481/dis.20100114ir
Cross cultural studies on adolescent cannabis use and psychosis
Konings, M. (2011) · Research Publications (Maastricht University) · doi:10.26481/dis.20111222mk
Epidemiological and biological mechanisms of cannabis as cause of psychosis
Kuepper, R. (2012) · Research Publications (Maastricht University) · doi:10.26481/dis.20120504rk
The acute effects of cannabinoids in patients with psychotic illness
Henquet, C., Sewell, A., Kuepper, R., Ranganathan, M., & D’Souza, D. C. (2011) · Cambridge University Press eBooks · doi:10.1017/cbo9780511706080.019
Cannabis, schizophrenia and other psychoses : longitudinal studies on Swedish conscripts
Manrique-Garcia, E. (2014) · Figshare
Baldacchino, A., Blair, H. A., Sommer, B., Tan, L., Riglietta, M., Tidone, L., Scherbaum, N., Grosse-Vehne, E., Little, H. J., Galea, S., et al. (2012) · Mental Health and Substance Use · doi:10.1080/17523281.2012.658081
Malchow, B. (2013) · eDiss (Georg-August-Universität Göttingen) · doi:10.53846/goediss-4033
White, M., ROCHE, A. M., Trifonoff, A., Matalon, E., & Elkins, K. (2014)
Wagner, B. (2015) · cIRcle (University of British Columbia) · doi:10.14288/1.0166395
Biologist and Former Head of Health Education
Brett, M. (2016)
An integrative overview of the cannabinergic system and mental health
Prospero-Garcia, O. E., Laboratorio de Cannabinoides, D. D. F., Rueda‐Orozco, P. E., Belmont, O. A., Ruiz‐Contreras, A. E., Méndez‐Díaz, M., Departamento de Neurofisiología del Desarrollo y Neurofisiología, I. D. N., & Laboratorio de Neurogenómica Cognitiva, C. D. P. Y. N. (2017) · Salud Mental · doi:10.17711/sm.0185-3325.2017.015
Cannabis, Migration, and Psychosis Onset
Kokona, A., Tarricone, I., Forti, M. D., & Carra, E. (2017) · Elsevier eBooks · doi:10.1016/b978-0-12-800756-3.00010-7 · Cited by 1
[Gigantiform cementoma (case report)].
Punwutikorn, J. (1982) · PubMed
Schizophrenia related genes and its molecular treatments: systematic review and analysis
Escuela de Ciencias Biológicas en Ingeniería, U. Y. T. E., Bravo, I., Figueroa, F., Escuela de Ciencias Biológicas en Ingeniería, U. Y. T. E., Preciado, C., & Escuela de Ciencias Biológicas en Ingeniería, U. Y. T. E. (2018) · Bionatura · doi:10.21931/rb/2018.03.02.13
Komplexe Dynamik der Komorbidität Schizophrenie und Cannabiskonsum
Schnell, T. G. (2018) · Springer eBooks · doi:10.1007/978-3-662-45995-9_20-1
Quelle est la place de la consommation de substances dans les troubles psychotiques émergents ?
Taleb, M. H., Benamar, S. A., & Keddache, C. (2019) · Elsevier eBooks · doi:10.1016/b978-2-294-76179-9.00007-3
Biologically relevant subgroups within the schizophrenia syndrome
Lubeiro, A. (2019) · UVaDOC UVaDOC University of Valladolid Documentary Repository (University of Valladolid) · doi:10.35376/10324/39211
Young adult perceptions of cannabis use
Harris-Lane, L. M. (2019) · Memorial University Research Repository (Memorial University)
(2013) · CRC Press eBooks · doi:10.1201/b15462-35
Regards croisés sur le cannabis
Seutin, V., Scuvée‐Moreau, J., & Quertemont, É. (2010) · Mardaga eBooks · doi:10.3917/mard.seuti.2010.01.0245
Altamura, A. C., & Mauri, M. C. (2010) · Faculty Opinions – Post-Publication Peer Review of the Biomedical Literature · doi:10.3410/f.5336956.5288054
Treves, N., Yakirevich-Amir, N., Ahmad, W. A., Bonne, O. B., Davidson, E. M., Keeling, K., Hall, B., Dautrich, T., & Matok, I. (2024) · European Archives of Psychiatry and Clinical Neuroscience · doi:10.1007/s00406-024-01812-0
Ghalib, K., & Harper, G. P. (2009) · American Psychiatric Association Publishing eBooks · doi:10.1176/appi.books.9781615378029.lg10
Chapter 12. Health Promotion and Prevention of Somatic Illnesses in Psychiatric Settings
Hackman, A. L., Hekler, E. B., & Dixon, L. B. (2009) · American Psychiatric Association Publishing eBooks · doi:10.1176/appi.books.9781615378029.lg12
McGriff, J. A., McDonald, W. M., Duberstein, P. R., & Lyness, J. M. (2009) · American Psychiatric Association Publishing eBooks · doi:10.1176/appi.books.9781615378029.lg11
Chapter 3. Prevention of Mood Disorders
Borba, C. P. C., & Druss, B. G. (2009) · American Psychiatric Association Publishing eBooks · doi:10.1176/appi.books.9781615378029.lg03
Chapter 4. Prevention of Anxiety Disorders
Bienvenu, O. J., Siegel, D. J., & Ginsburg, G. S. (2009) · American Psychiatric Association Publishing eBooks · doi:10.1176/appi.books.9781615378029.lg04
(2009) · American Psychiatric Association Publishing eBooks · doi:10.1176/appi.books.9781615378029.index
Chapter 9. Prevention of Family Violence
Rogers, K., Baumgardner, B., Connors, K., Martens, P., & Kiser, L. J. (2009) · American Psychiatric Association Publishing eBooks · doi:10.1176/appi.books.9781615378029.lg09
Metadata
- Authors
- Ferdinand, R. F., Sondeijker, F., Van Der Ende, J., Selten, J., Huizink, A., & Verhulst, F. C.
- Affiliations
- Erasmus MC (NL)
- University Medical Center Utrecht (NL)
- Corresponding author
- Ferdinand, Robert F.
- Venue
- Addiction
- Publisher
- Wiley
- Published
- 2005-04-22
- Volume
- 100
- Issue
- 5
- Pages
- 612-618
- ISSN
- 0965-2140 (ISSN-L)
- 1360-0443
- OpenAlex
- W1993562858
- Cited by
- 212
- References
- 42
- Citations by year
- 2026: 1 · 2025: 1 · 2024: 4 · 2023: 7 · 2022: 4 · 2021: 5 · 2020: 10 · 2019: 13 · 2018: 12 · 2017: 10 · 2016: 9 · 2015: 7 · 2014: 10 · 2013: 6 · 2012: 12
- FWCI
- 8.08
- Type
- journal article
- Language
- en
- Open access
- closed
- Locations
- Addiction (publishedVersion)
- PubMed (publishedVersion)
- EUR Research Repository (Erasmus University Rotterdam) (submittedVersion)
- Radboud Repository (Radboud University) (submittedVersion)
- VU Research Portal (submittedVersion)
- Data Archiving and Networked Services (DANS) (submittedVersion)
- Topics
- Health Sciences › Medicine › Pharmacology (medical) › Cannabis and Cannabinoid Research
- Health Sciences › Medicine › Psychiatry and Mental health › Schizophrenia research and treatment
- Health Sciences › Medicine › Epidemiology › Substance Abuse Treatment and Outcomes
- Keywords
- cannabis use, psychotic symptoms, psychosis risk, adolescents, young adults, bidirectional causality, onset time, lifetime cannabis use
- MeSH terms
- Adolescent, Marijuana Abuse, Child, Child, Preschool, Female, Follow-Up Studies, Humans, Male, Netherlands, Psychoses, Substance-Induced, Psychotic Disorders, Risk Factors, Cohort Studies
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review